This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2006 Jan-Feb;34(1):3-5.

doi: 10.1111/j.1442-9071.2006.01164.x.

Resisting susceptibility: bacterial keratitis and generations of antibiotics

Charles N J McGhee, Rachael Niederer

PMID: 16451250
DOI: 10.1111/j.1442-9071.2006.01164.x

Editorial

Resisting susceptibility: bacterial keratitis and generations of antibiotics

Charles N J McGhee et al. Clin Exp Ophthalmol. 2006 Jan-Feb.

. 2006 Jan-Feb;34(1):3-5.

doi: 10.1111/j.1442-9071.2006.01164.x.

Authors

Charles N J McGhee, Rachael Niederer

PMID: 16451250
DOI: 10.1111/j.1442-9071.2006.01164.x

No abstract available

PubMed Disclaimer

Comment on

Bacteria commonly isolated from keratitis specimens retain antibiotic susceptibility to fluoroquinolones and gentamicin plus cephalothin.
Ly CN, Pham JN, Badenoch PR, Bell SM, Hawkins G, Rafferty DL, McClellan KA. Ly CN, et al. Clin Exp Ophthalmol. 2006 Jan-Feb;34(1):44-50. doi: 10.1111/j.1442-9071.2006.01143.x. Clin Exp Ophthalmol. 2006. PMID: 16451258

Similar articles

The role of cultures in the management of ulcerative keratitis.
McLeod SD. McLeod SD. Cornea. 1997 Jul;16(4):381-2. Cornea. 1997. PMID: 9220232 No abstract available.
Microbiologic investigation of suspected microbial keratitis.
Allan BD, Morlet N, Dart JK. Allan BD, et al. Ophthalmology. 1996 Aug;103(8):1165-6. doi: 10.1016/s0161-6420(96)30528-9. Ophthalmology. 1996. PMID: 8764781 No abstract available.
Bacterial susceptibility to topical antimicrobials and clinical outcome in bacterial keratitis.
Kaye S, Tuft S, Neal T, Tole D, Leeming J, Figueiredo F, Armstrong M, McDonnell P, Tullo A, Parry C. Kaye S, et al. Invest Ophthalmol Vis Sci. 2010 Jan;51(1):362-8. doi: 10.1167/iovs.09-3933. Epub 2009 Aug 13. Invest Ophthalmol Vis Sci. 2010. PMID: 19684005
Current diagnosis and treatment of corneal ulcers.
Benson WH, Lanier JD. Benson WH, et al. Curr Opin Ophthalmol. 1998 Aug;9(4):45-9. doi: 10.1097/00055735-199808000-00008. Curr Opin Ophthalmol. 1998. PMID: 10387468 Review.
Controversies in management of bacterial keratitis.
Charukamnoetkanok P, Pineda R 2nd. Charukamnoetkanok P, et al. Int Ophthalmol Clin. 2005 Fall;45(4):199-210. doi: 10.1097/01.iio.0000177432.66775.d2. Int Ophthalmol Clin. 2005. PMID: 16199977 Review. No abstract available.

See all similar articles

Cited by

A New Topical Eye Drop Containing LyeTxI-b, A Synthetic Peptide Designed from A Lycosa erithrognata Venom Toxin, Was Effective to Treat Resistant Bacterial Keratitis.
Silva CND, Silva FRD, Dourado LFN, Reis PVMD, Silva RO, Costa BLD, Nunes PS, Amaral FA, Santos VLD, de Lima ME, Silva Cunha Júnior AD. Silva CND, et al. Toxins (Basel). 2019 Apr 4;11(4):203. doi: 10.3390/toxins11040203. Toxins (Basel). 2019. PMID: 30987317 Free PMC article.
Antibacterial activity and cytotoxicity of PEGylated poly(amidoamine) dendrimers.
Lopez AI, Reins RY, McDermott AM, Trautner BW, Cai C. Lopez AI, et al. Mol Biosyst. 2009 Oct;5(10):1148-56. doi: 10.1039/b904746h. Epub 2009 Jul 3. Mol Biosyst. 2009. PMID: 19756304 Free PMC article.
Evaluation of antibacterial efficacy of photo-activated riboflavin using ultraviolet light (UVA).
Makdoumi K, Bäckman A, Mortensen J, Crafoord S. Makdoumi K, et al. Graefes Arch Clin Exp Ophthalmol. 2010 Feb;248(2):207-12. doi: 10.1007/s00417-009-1231-2. Epub 2009 Nov 18. Graefes Arch Clin Exp Ophthalmol. 2010. PMID: 19921518

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information